Arrowhead Pharmaceuticals Inc. buy Bank of America Co.
Start price
02.01.24
/
50%
€28.47
Target price
02.01.25
€33.76
Performance (%)
-33.26%
End price
03.01.25
€19.00
Summary
This prediction ended on 03.01.25 with a price of €19.00. The BUY prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc. performed very badly with a performance of -33.26%. Bank_of_America_Co_ has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 2.936% | 2.936% | 292.639% |
| iShares Core DAX® | -0.479% | -12.062% | -2.949% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 9.585% |
| iShares Nikkei 225® | -0.143% | -12.633% | 20.316% |
| iShares S&P 500 | -2.266% | -5.049% | 5.803% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target raised by analysts at Bank of America Co. from $29.00 to $37.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€47.40
01.12.25
01.12.25
€53.46
01.12.26
01.12.26
5.78%
27.03.26
27.03.26
Stopped prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€59.64
09.12.25
09.12.25
€69.55
09.12.26
09.12.26
-15.93%
27.03.26
27.03.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.76
04.12.23
04.12.23
€26.71
04.12.24
04.12.24
1.56%
05.12.24
05.12.24